Skip to main content
User account menu
Log in
Search
Main navigation
Home
Data Sources
Studies
Institutions
Networks
What's new
Support
Home
University of Oslo
First published
01/02/2024
Last updated
01/02/2024
Institution
Download as PDF
Page content
Institution identification
Institution description
Institution details
Contact
Institution identification
Institution ID
3331483
Institution full name and acronym
University of Oslo
ENCePP partner
No
Institution details
Experience with collecting data directly from individual patients or respondents:
No
Interest in carrying out research that is funded by pharmaceutical companies:
No
Network(s) of which the institution is a member
Data Analysis and Real World Interrogation Network (DARWIN EU®)
Data sources owned by the institution
Norwegian Linked Health registry at University of Oslo
05/12/2024 - 13:17
Norwegian Linked Health registry at University of Oslo, Pregnancy cohort
05/12/2024 - 19:02
Studies conducted by the institution
A Post-Authorisation Safety Study (PASS) of ABRYSVO (Respiratory Syncytial Virus Stabilised Prefusion Subunit Vaccine) in Pregnant Women and their Offspring in a Real World Setting in Europe and UK
ADEPT: feasibility of estimating the risk of adverse pregnancy, neonatal and child outcomes following either in utero ASM exposure through the mother, or peri-conceptional ASM exposure through the father
CONSIGN study: COVID-19 infection and medicines in pregnancy - a multinational registry based study
Demonstrating solutions for studying intermittent medication exposures in diseases with episodic manifestations during pregnancy: application to medication for migraine in pregnancy
Description of international collaboration in the area of medicines use and effects in COVID-19 affected pregnancies (CONSIGN-International))
Exposure to SSRI/SNRI and depression in pregnancy and long-term childhood outcomes: the effect of modifying factors
Monitoring safety of Spikevax in pregnancy: an observational study using routinely collected health data in five European countries (COVID-19)
mRNA-1273-P910: Clinical course, outcomes and risk factors of myocarditis and pericarditis following administration of Moderna vaccines targeting SARS-CoV-2.
Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe (COVID-19)
SAFETY-VAC: Background incidence estimation of flares of pre-existing chronic diseases using pan-European electronic healthcare data sources. (SAFETY VAC)
SAFETY-VAC: Network of Data Sources for Vaccine Safety Evaluation
SAFETY-VAC: Phenotype proposal and rates of immunocompromised populations in real-world data sources.
Share this page